Amneal Wins FDA Approval for Expanded Iohexol Portfolio
Bridgewater, N.J., July 17, 2026 Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved additional...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Bridgewater, N.J., July 17, 2026 Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved additional...
TORONTO, Ontario, June 30, 2026 Apotex Health Corp. announced that Health Canada has approved SEVMIAâ„¢ (semaglutide injection), making it...
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
PRAGUE / BRUSSELS, April 27, 2026 Zentiva has filed an appeal before the Court of Justice of the European...
